ArticleESMO gastrointestinal oncology2026
Effectiveness of FTD/TPI plus bevacizumab and impact of prior bevacizumab exposure in patients with mCRC: the Italian FLOWER study.
G Trovato et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.